课题基金 / 基金详情

Coagulation system effectors as regulators of tumour dormancy and therapeutic targets

Coagulation system effectors as regulators of tumour dormancy and therapeutic targets
凝血系统效应子作为肿瘤休眠和治疗靶点的调节剂
批准号：
292199
负责人：
Rak Janusz
金额：
$51.73万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2013
资助国家：
加拿大
项目状态：
已结题
起止时间：
2013-09-01 至 2018-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=292199&lang=en
关键词：
Angiogenesis Antiangiogenesis Anticoagulants Biomarker Coagulation Factors Dormancy Glioma Inflammation Oncogenes Targeted Agents

项目摘要

项目成果

Rak Janusz的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cancers can be controlled even if the mutated cells remain viable, but are locked in a state known as dormancy. One feature of progressive cancers is the activation of the blood clotting (coagulation) system. We study brain tumours where we observed that
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting exosomal mediators of vascular pathology in glioblastoma
Targeting vascular mechanisms of cancer progression
Oncogene-containing microvesicles as mediators and messengers of tumour progression
Tissue factor in tumour progression and angiogenesis
海外基金